James V. Caruso, President and CEO at Cellectar Biosciences, Inc. (CLRB), bought 93,896 shares at $2.12 ($199K) on 2016-04-20, disclosed to the SEC on 2016-04-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.12 | 46,948 | $100K | 50.0% |
| 2 | $2.12 | 46,948 | $100K | 50.0% |
| Total | $2.12 avg | 93,896 | $199K | 100% |
| Filing → |
| CLRB | BUY | 2021-03-05 | $9K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $50K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $25K | — | Filing → |